|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/13/17 Vivos Inc 10-Q 9/30/17 53:2.8M M2 Compliance/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 264K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
11: R1 Document and Entity Information HTML 37K
12: R2 Condensed Balance Sheets HTML 89K
13: R3 Condensed Balance Sheets (Parenthetical) HTML 35K
14: R4 Condensed Statements of Operations (Unaudited) HTML 75K
15: R5 Condensed Statements of Cash Flow (Unaudited) HTML 105K
16: R6 Basis of Presentation and Significant Accounting HTML 40K
Policies
17: R7 Going Concern HTML 27K
18: R8 Fixed Assets HTML 26K
19: R9 Intangible Assets HTML 24K
20: R10 Related Party Transactions HTML 22K
21: R11 Convertible Notes Payable HTML 40K
22: R12 Common Stock Options, Warrants, and Restricted HTML 69K
Stock Units
23: R13 Stockholders' Equity HTML 23K
24: R14 Supplemental Cash Flow Information HTML 24K
25: R15 Commitments and Contingencies HTML 20K
26: R16 Subsequent Events HTML 20K
27: R17 Basis of Presentation and Significant Accounting HTML 45K
Policies (Policies)
28: R18 Basis of Presentation and Significant Accounting HTML 33K
Policies (Tables)
29: R19 Fixed Assets (Tables) HTML 25K
30: R20 Intangible Assets (Tables) HTML 24K
31: R21 Convertible Notes Payable (Tables) HTML 36K
32: R22 Common Stock Options, Warrants, and Restricted HTML 72K
Stock Units (Tables)
33: R23 Basis of Presentation and Significant Accounting HTML 27K
Policies - Schedule of Fair Value of Financial
Instruments (Details)
34: R24 Going Concern (Details Narrative) HTML 34K
35: R25 Fixed Assets (Details Narrative) HTML 19K
36: R26 Fixed Assets - Schedule of Fixed Assets (Details) HTML 27K
37: R27 Intangible Assets (Details Narrative) HTML 20K
38: R28 Intangible Assets - Schedule of Intangible Assets HTML 25K
(Details)
39: R29 Related Party Transactions (Details Narrative) HTML 36K
40: R30 Convertible Notes Payable (Details Narrative) HTML 65K
41: R31 Convertible Notes Payable - Schedule of HTML 42K
Convertible Notes Payable (Details)
42: R32 Convertible Notes Payable - Schedule of HTML 59K
Convertible Notes Payable (Details)
(Parenthetical)
43: R33 Common Stock Options, Warrants and Restricted HTML 24K
Stock Units (Details Narrative)
44: R34 Common Stock Options, Warrants and Restricted HTML 69K
Stock Units - Schedule Summarizes Changes in Stock
Option (Details)
45: R35 Common Stock Options, Warrants and Restricted HTML 69K
Stock Units - Schedule Summarizes Changes in Stock
Warrants (Details)
46: R36 Common Stock Options, Warrants and Restricted HTML 35K
Stock Units - Schedule Summarizes Changes in
Restricted Stock Units (Details)
47: R37 Stockholders' Equity (Details Narrative) HTML 80K
48: R38 Supplemental Cash Flow Information (Details HTML 73K
Narrative)
49: R39 Commitments and Contingencies (Details Narrative) HTML 19K
50: R40 Subsequent Events (Details Narrative) HTML 37K
52: XML IDEA XML File -- Filing Summary XML 92K
51: EXCEL IDEA Workbook of Financial Reports XLSX 45K
5: EX-101.INS XBRL Instance -- admd-20170930 XML 729K
7: EX-101.CAL XBRL Calculations -- admd-20170930_cal XML 126K
8: EX-101.DEF XBRL Definitions -- admd-20170930_def XML 353K
9: EX-101.LAB XBRL Labels -- admd-20170930_lab XML 680K
10: EX-101.PRE XBRL Presentations -- admd-20170930_pre XML 520K
6: EX-101.SCH XBRL Schema -- admd-20170930 XSD 116K
53: ZIP XBRL Zipped Folder -- 0001493152-17-012763-xbrl Zip 71K
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying quarterly report of Advanced Medical Isotope Corporation (the “Company”) on Form 10-Q for the quarter ended September 30, 2017 (the “Report”), the undersigned, Michael Korenko, Chief Executive Officer of the Company, and L. Bruce Jolliff, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 13, 2017 | ||
| By: | /s/ Michael K. Korenko | |
| Name: | Michael K. Korenko | |
| Title: | Chief Executive Officer |
| By: | /s/ L. Bruce Jolliff | |
| Name: | L. Bruce Jolliff | |
| Title: | Chief Financial Officer |
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/13/17 | None on these Dates | ||
| For Period end: | 9/30/17 | |||
| List all Filings | ||||